TLDR Systemic retinoids do not increase COVID-19 risk or severity.
The study evaluated the risk of COVID-19 in 186 patients undergoing systemic retinoid therapy, specifically isotretinoin and acitretin, compared to a control group not on retinoid therapy. Results showed that 1.07% of patients in the retinoid group and 4.3% in the control group were diagnosed with COVID-19, with no cases in patients receiving acitretin. There was no significant difference in COVID-19 incidence or severity between the groups. The study concluded that systemic retinoids did not increase the risk or severity of COVID-19, suggesting they were a safe treatment option during the pandemic.
47 citations
,
April 2020 in “Dermatologic Therapy” Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.
12 citations
,
January 2011 in “Dermatologic Surgery” Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.
6 citations
,
September 2012 in “Our Dermatology Online” Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.
1 citations
,
January 2018 in “Indian Journal of Dermatology/Indian journal of dermatology” Retinoids might cause temporary hyperthyroidism in some patients.
6 citations
,
December 1987 in “Mayo Clinic proceedings” Retinoids are effective for severe acne and psoriasis but can cause serious side effects and birth defects.
January 2017 in “Clinical approaches and procedures in cosmetic dermatology” Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.